1. Roffi, M, Patrono, C, Collet, JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 267–315.
Google Scholar | Crossref | Medline | ISI2. Steg, PG, Dabbous, OH, Feldman, LJ, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: Observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004; 109: 494–499.
Google Scholar | Crossref | Medline | ISI3. Ranasinghe, I, Naoum, C, Aliprandi-Costa, B, et al. Management and outcomes following an acute coronary event in patients with chronic heart failure 1999–2007. Eur J Heart Fail 2012; 14: 464–472.
Google Scholar | Crossref | Medline | ISI4. Bahit, MC, Lopes, RD, Clare, RM, et al. Heart failure complicating non-ST-segment elevation acute coronary syndrome: Timing, predictors, and clinical outcomes. JACC Heart Fail 2013; 1: 223–229.
Google Scholar | Crossref | Medline5. Steg, PG, Kerner, A, Van de Werf, F, et al. Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure. Circulation 2008; 118: 1163–1171.
Google Scholar | Crossref | Medline | ISI6. Fox, KA, Steg, PG, Eagle, KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 2007; 297: 1892–1900.
Google Scholar | Crossref | Medline | ISI7. Steg, PG, Mehta, SR, Pollack, CV, et al. Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non-ST-segment elevation acute coronary syndromes with a planned early invasive strategy. Am Heart J 2012; 164: 817–24 e13.
Google Scholar | Medline8. Steg, PG, Mehta, SR, Pollack, CV, et al. Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: The TAO randomized clinical trial. JAMA 2013; 310: 1145–1155.
Google Scholar | Crossref | Medline | ISI9. Deharo, P, Ducrocq, G, Bode, C, et al. Timing of angiography and outcomes in high-risk patients with non-ST-segment-elevation myocardial infarction managed invasively: Insights from the TAO trial (Treatment of Acute Coronary Syndrome With Otamixaban). Circulation 2017; 136: 1895–1907.
Google Scholar | Crossref | Medline10. Killip, T, Kimball, JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20: 457–464.
Google Scholar | Crossref | Medline | ISI11. Granger, CB, Goldberg, RJ, Dabbous, O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345–2353.
Google Scholar | Crossref | Medline12. Khot, UN, Jia, G, Moliterno, DJ, et al. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: The enduring value of Killip classification. JAMA 2003; 290: 2174–2181.
Google Scholar | Crossref | Medline | ISI13. van Diepen, S, Chen, AY, Wang, TY, et al. Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction. Am Heart J 2014; 167: 267–73 e1.
Google Scholar | Crossref | Medline14. Jedrzkiewicz, S, Goodman, SG, Yan, RT, et al. Evaluation of left ventricular ejection fraction in non-ST-segment elevation acute coronary syndromes and its relationship to treatment. Am Heart J 2010; 159: 605–611.
Google Scholar | Crossref | Medline | ISI15. Solomon, SD, Zelenkofske, S, McMurray, JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005; 352: 2581–2588.
Google Scholar | Crossref | Medline | ISI16. Pokorney, SD, Al-Khatib, SM, Sun, JL, et al. Sudden cardiac death after acute heart failure hospital admission: Insights from ASCEND-HF. Eur J Heart Fail 2018; 20: 525–532.
Google Scholar | Crossref | Medline17. Hwang, SJ, Melenovsky, V, Borlaug, BA. Implications of coronary artery disease in heart failure with preserved ejection fraction. J Am Coll Cardiol 2014; 63: 2817–2827.
Google Scholar | Crossref | Medline18. Uretsky, BF, Thygesen, K, Armstrong, PW, et al. Acute coronary findings at autopsy in heart failure patients with sudden death: Results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation 2000; 102: 611–616.
Google Scholar | Crossref | Medline | ISI19. Mentz, RJ, Lazzarini, V, Fiuzat, M, et al. Is there a rationale for antiplatelet therapy in acute heart failure? Circ Heart Fail 2013; 6: 869–876.
Google Scholar | Crossref | Medline | ISI20. Minamino-Muta, E, Kato, T, Morimoto, T, et al. Causes of death in patients with severe aortic stenosis: An observational study. Sci Rep 2017; 7: 14723.
Google Scholar | Crossref | Medline21. Hofmann, U, Frantz, S. How can we cure a heart ‘in flame’? A translational view on inflammation in heart failure. Basic Res Cardiol 2013; 108: 356.
Google Scholar | Crossref | Medline22. Hasin, T, Gerber, Y, Weston, SA, et al. Heart failure after myocardial infarction is associated with increased risk of cancer. J Am Coll Cardiol 2016; 68: 265–271.
Google Scholar | Crossref | Medline | ISI23. Puymirat, E, Simon, T, Cayla, G, et al. Acute myocardial infarction: Changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015. Circulation 2017; 136: 1908–1919.
Google Scholar | Crossref | Medline24. Stevenson, LW, Perloff, JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989; 261: 884–888.
Google Scholar | Crossref | Medline | ISI25. Mello, BH, Oliveira, GB, Ramos, RF, et al. Validation of the Killip-Kimball classification and late mortality after acute myocardial infarction. Arq Bras Cardiol 2014; 103: 107–117.
Google Scholar | Medline26. Nunez-Gil, IJ, Garcia-Rubira, JC, Luaces, M, et al. Mild heart failure is a mortality marker after a non-ST-segment acute myocardial infarction. Eur J Intern Med 2010; 21: 439–443.
Google Scholar | Crossref | Medline | ISI